# Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome

> **NCT07460908** · NA · COMPLETED · sponsor: **Lahore General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Hepatorenal Syndrome

## Interventions

- **DRUG:** terlipressin
- **DRUG:** Octreotide (drug)

## Key facts

- **NCT ID:** NCT07460908
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07460908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07460908, "Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07460908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*